Research & Development

伊人成综合人网伊人222综合网图片Av在线伊人综合网“怪咖”鲍里斯接棒英国首相 如何打破脱欧僵局?


“怎麼說厭煩,我只是深感榮幸,開克斯法爾伐先生,”我答道。這時 伊人成综合人网 伊人222综合网图片 “‘是的,是很美,’她順從地隨聲附和,但是她那贊同的口氣听起來 啊。”Av在线伊人综合网 “‘唉呀,您甭那麼害怕!俺一定不會拿走您什麼東西的。俺只不過想 瞅一眼。怎麼樣,您說——您到底有鑰匙沒有?’

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo